Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
- Update frequency
- every 5 days
- Episodes
- 347
- Years Active
- 2015 - 2025
Exploring the Treatment Landscape for Head & Neck Cancer
Guest: Nabil F. Saba, MD, FACP
Emerging research on head and neck cancer has moved away from HPV-negative diseases upon the discovery of HPV-positive diseases, spe…
How COVID-19 Has Changed the Way We Approach Head & Neck Cancer Care
Guest: Nabil F. Saba, MD, FACP
Since head and neck cancer is still to a large extent a surgical disease, the COVID-19 pandemic had an immediate impact on its manag…
How COVID-19 Has Changed the Way We Approach Head & Neck Cancer Care
Guest: Nabil F. Saba, MD, FACP
Since head and neck cancer is still to a large extent a surgical disease, the COVID-19 pandemic had an immediate impact on its manag…
The COVID-19 Pandemic & Dangerous Delays in Cancer Screenings
Guest: Therese T. Bevers, MD
Fear of the COVID-19 pandemic has led to added safety precautions that have prevented patients from receiving much-needed cancer scree…
The COVID-19 Pandemic & Dangerous Delays in Cancer Screenings
Guest: Therese T. Bevers, MD
Fear of the COVID-19 pandemic has led to added safety precautions that have prevented patients from receiving much-needed cancer scree…
HIPEC: A Novel Treatment for Advanced Abdominal Cancers
Guest: Nabil Wasif, MD
Image: Mayo Foundation For Medical Education and Research. All Rights Reserved.
Short for hyperthermic intraperitoneal chemotherapy, HIPEC…
HIPEC: A Novel Treatment for Advanced Abdominal Cancers
Guest: Nabil Wasif, MD
Image: Mayo Foundation For Medical Education and Research. All Rights Reserved.
Short for hyperthermic intraperitoneal chemotherapy, HIPEC…
Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
Guest: Richard Wender, MD
From oncologists to primary care, physicians are witnessing an alarming trend in younger patients: the rising risk of colorectal cancer.…
Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
Guest: Richard Wender, MD
From oncologists to primary care, physicians are witnessing an alarming trend in younger patients: the rising risk of colorectal cancer.…
Not Quite a Cancer Vaccine: Selling HPV & Cervical Cancer
Human papillomavirus (HPV) infection remains one of the most common sexually transmitted infections in both females and males, with about 9 in 10 people …
Not Quite a Cancer Vaccine: Selling HPV & Cervical Cancer
Human papillomavirus (HPV) infection remains one of the most common sexually transmitted infections in both females and males, with about 9 in 10 people …
What to Know About a State-of-the-Art Approach to GIST Treatment
Guest: Ronald DeMatteo, MD, FACS
A Gastrointestinal Stromal Tumor (GIST) is a rare sarcoma that begins in the digestive tract or stomach, with an incident rate i…
What to Know About a State-of-the-Art Approach to GIST Treatment
Guest: Ronald DeMatteo, MD, FACS
A Gastrointestinal Stromal Tumor (GIST) is a rare sarcoma that begins in the digestive tract or stomach, with an incident rate i…
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
Oncologists Dr. Sanjeeve Bala and Dr. Abhilasha Nair from FDA’s Oncology Center of Excellence discuss the recent approval of bevacizumab-awwb, a biosimilar to US-licensed Avastin, marketed as MVASI. …
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
Oncologists Dr. Sanjeeve Bala and Dr. Abhilasha Nair from FDA’s Oncology Center of Excellence discuss the recent approval of bevacizumab-awwb, a biosimilar to US-licensed Avastin, marketed as MVASI. …
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
Guest: Robert Vonderheide, MD
For years, the foundations of cancer treatment, surgery, chemotherapy, and radiation therapy were utilized with the objective of we…
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
Guest: Robert Vonderheide, MD
For years, the foundations of cancer treatment, surgery, chemotherapy, and radiation therapy were utilized with the objective of we…
Pancreatic Cancer: The Hunt to Catch a Silent Killer
Guest: Harish Lavu, MD
Pancreatic cancer is projected to become the second leading cause of cancer-related death in the United States by 2020. This is due, in lar…
Pancreatic Cancer: The Hunt to Catch a Silent Killer
Guest: Harish Lavu, MD
Pancreatic cancer is projected to become the second leading cause of cancer-related death in the United States by 2020. This is due, in lar…
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
FDA medical oncologists discuss the approval of osimertinib for EGFR mutation-positive non-small cell lung cancer.
Released July 28, 2017